OligoNova Hub – from Ideas to Oligonucleotide Therapies

OligoNova Hub provides state-of-the-art drug discovery infrastructure and expertise to academic researchers, to support the translation of fundamental research findings into patient-benefitting therapeutic molecules. OligoNova Hub is an integrated part of the national SciLifeLab Drug Discovery and Development Platform (DDD), is organized within the Sahlgrenska Academy at the University of Gothenburg, and located in the AstraZeneca BioVenture Hub in Mölndal, Sweden.